Colonoscopy Outcomes in Average-Risk Screening Equivalent Young Adults: Data From the New Hampshire Colonoscopy Registry.
Journal
The American journal of gastroenterology
ISSN: 1572-0241
Titre abrégé: Am J Gastroenterol
Pays: United States
ID NLM: 0421030
Informations de publication
Date de publication:
01 01 2021
01 01 2021
Historique:
received:
10
02
2020
accepted:
03
07
2020
pubmed:
25
8
2020
medline:
5
2
2021
entrez:
25
8
2020
Statut:
ppublish
Résumé
Data are needed to further inform the American Cancer Society recommendation to begin colorectal cancer (CRC) screening at age 45. We used the New Hampshire Colonoscopy Registry to compare the prevalence of advanced neoplasia (AN) in an "average-risk screening equivalent" group aged 45-49 years with patients aged 50-54 years and older receiving screening colonoscopy. Colonoscopies in adults older than 50 years of age usually have diagnostic indications of varying clinical significance. We combined patients older than 50 years with diagnostic indications (abdominal pain and constipation) expected to yield AN prevalence similar to screening low AN risk and those with a screening indication to form an "average-risk screening equivalent" group. We excluded high-risk indications (e.g., bleeding and anemia), surveillance examinations, and patients with a first-degree family history of CRC, incomplete examinations, and poor bowel preparation. We calculated prevalence/adjusted risks for AN (≥1 cm, villous, high-grade dysplasia, and CRC) and clinically significant serrated polyps (large [≥1 cm] hyperplastic polyps, sessile serrated polyp, traditional serrated adenomas, and proximal hyperplastic polyp ≥ 5 mm). In our sample (n = 40,812), AN prevalence was as follows: <40 years (1.1%), 40-44 years (3.0%), 45-49 years (3.7%), 50-54 years (3.6%), 55-59 years (5.1%), and 60+ years (6.7%) (P < 0.0001 across all groups). The prevalence of both AN and clinically significant serrated polyp was similar in the 45-49 and 50-54 years' age groups. Furthermore, the prevalence of AN increased significantly in the 40-44 group as compared to that in the <40 years group. Adjusted analyses confirmed these results. The diagnostic indications considered to have low risk were not predictive of AN. New Hampshire Colonoscopy Registry data, demonstrating an increase in AN risk starting at age 40 and a similar prevalence for individuals aged 45-49 and those ages 50-54, provide clinically useful evidence for optimization of prevention and the age to start screening. However, this is a complex issue involving additional considerations that will need to be addressed.
Identifiants
pubmed: 32833734
pii: 00000434-202101000-00029
doi: 10.14309/ajg.0000000000000820
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
171-179Informations de copyright
Copyright © 2020 by The American College of Gastroenterology.
Références
Siegel RL, Miller KD, Fedewa SA, et al. Colorectal cancer statistics, 2017. CA Cancer J Clin 2017;67:177–93.
Siegel RL, Fedewa SA, Anderson WF, et al. Colorectal cancer incidence patterns in the United States, 1974-2013. J Natl Cancer Inst 2017;109:djw322.
Siegel RL, Jemal A, Ward EM. Increase in incidence of colorectal cancer among young men and women in the United States. Cancer Epidemiol Biomarkers Prev 2009;18:1695–8.
Siegel RL, Miller KD, Jemal A. Colorectal cancer mortality rates in adults aged 20 to 54 Years in the United States, 1970-2014. JAMA 2017;318:572–4.
Welch HG, Robertson DJ. Colorectal cancer on the decline--why screening can't Explain it all. N Engl J Med 2016;374:1605–7.
Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: Incidence-SEER 9 Regs Research Data With Delay Adjustment, Nov. 2018 Sub (1975-2016) <Katrina/Rita Population Adjustment>-Linked To County Attributes-Total US, 1969-2017 Counties. National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program Surveillance Systems Branch; 2019.
Shapiro JA, Klabunde CN, Thompson TD, et al. Patterns of colorectal cancer test Use, including CT colonography, in the 2010 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev 2012;21:895–904.
Siegel RL, Miller KD, Goding Sauer A, et al. Colorectal cancer statistics, 2020. CA Cancer J Clin 2020;70:145.
Wolf AMD, Fontham ETH, Church TR, et al. Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society. CA Cancer J Clin 2018;68:250–81.
Cha JM, Kozarek RA, La Selva D, et al. Findings of diagnostic colonoscopy in young adults versus findings of screening colonoscopy in patients aged 50 to 54 years: A comparative study stratified by symptom category. Gastrointest Endosc 2015;82:138–45.
Imperiale TF, Wagner DR, Lin CY, et al. Results of screening colonoscopy among persons 40 to 49 years of age. N Engl J Med 2002;346:1781–5.
Jung YS, Ryu S, Chang Y, et al. Risk factors for colorectal neoplasia in persons aged 30 to 39 years and 40 to 49 years. Gastrointest Endosc 2015;81:637–45.e7.
Koo JE, Kim KJ, Park HW, et al. Prevalence and risk factors of advanced colorectal neoplasms in asymptomatic Korean people between 40 and 49 years of age. J Gastroenterol Hepatol 2017;32:98–105.
Rundle AG, Lebwohl B, Vogel R, et al. Colonoscopic screening in average-risk individuals ages 40 to 49 vs 50 to 59 years. Gastroenterology 2008;134:1311–5.
Lieberman DA, Holub JL, Moravec MD, et al. Prevalence of colon polyps detected by colonoscopy screening in asymptomatic black and white patients. JAMA 2008;300:1417–22.
Nagpal SJS, Mukhija D, Sanaka M, et al. Metachronous colon polyps in younger versus older adults: A case-control study. Gastrointest Endosc 2018;87:657–65.
Weaver DL, Rosenberg RD, Barlow WE, et al. Pathologic findings from the Breast Cancer Surveillance Consortium: Population-based outcomes in women undergoing biopsy after screening mammography. Cancer 2006;106:732–42.
Butterly LF, Goodrich M, Onega T, et al. Improving the quality of colorectal cancer screening: Assessment of familial risk. Dig Dis Sci 2010;55:754–60.
Greene MA, Butterly LF, Goodrich M, et al. Matching colonoscopy and pathology data in population-based registries: Development of a novel algorithm and the initial experience of the New Hampshire Colonoscopy Registry. Gastrointest Endosc 2011;74:334–40.
Anderson JC, Lisovsky M, Greene MA, et al. Factors associated with classification of hyperplastic polyps as sessile serrated adenomas/polyps on morphologic review. J Clin Gastroenterol 2018;52:524–9.
Singh H, Bay D, Ip S, et al. Pathological reassessment of hyperplastic colon polyps in a city-wide pathology practice: Implications for polyp surveillance recommendations. Gastrointest Endosc 2012;76:1003–8.
Rex DK, Ahnen DJ, Baron JA, et al. Serrated lesions of the colorectum: Review and recommendations from an expert panel. Am J Gastroenterol 2012;107:1315–29; quiz 1314, 1330.
Anderson JC, Robinson CM, Butterly LF. Increased risk of metachronous large serrated polyps in individuals with 5 to 9 mm proximal hyperplastic polyps: Data from the New Hampshire Colonoscopy Registry. Gastrointest Endosc 2020;92:387–393.
Wong S, Lidums I, Rosty C, et al. Findings in young adults at colonoscopy from a hospital service database audit. BMC Gastroenterol 2017;17:56.
Abualkhair WH, Zhou M, Ahnen D, et al. Trends in incidence of early-onset colorectal cancer in the United States among those approaching screening age. JAMA Netw Open 2020;3:e1920407.
Siegel RL, Torre LA, Soerjomataram I, et al. Global patterns and trends in colorectal cancer incidence in young adults. Gut 2019;68:2179–2185.
Chen CH, Tsai MK, Wen CP. Extending colorectal cancer screening to persons aged 40 to 49 years with immunochemical fecal occult blood test: A prospective cohort study of 513,283 individuals. J Clin Gastroenterol 2016;50:761–8.
Levin TR, Zhao W, Conell C, et al. Complications of colonoscopy in an integrated health care delivery system. Ann Intern Med 2006;145:880–6.
Arora G, Mannalithara A, Singh G, et al. Risk of perforation from a colonoscopy in adults: A large population-based study. Gastrointest Endosc 2009;69:654–64.
Rutter CM, Johnson E, Miglioretti DL, et al. Adverse events after screening and follow-up colonoscopy. Cancer Causes Control 2012;23:289–96.
Click B, Pinsky PF, Hickey T, et al. Association of colonoscopy adenoma findings with long-term colorectal cancer incidence. JAMA 2018;319:2021–31.
Gupta AK, Samadder J, Elliott E, et al. Prevalence of any size adenomas and advanced adenomas in 40- to 49-year-old individuals undergoing screening colonoscopy because of a family history of colorectal carcinoma in a first-degree relative. Gastrointest Endosc 2011;74:110–8.
Chung SJ, Kim YS, Yang SY, et al. Prevalence and risk of colorectal adenoma in asymptomatic Koreans aged 40-49 years undergoing screening colonoscopy. J Gastroenterol Hepatol 2010;25:519–25.
Kim HG, Cho YS, Cha JM, et al. Risk of metachronous neoplasia on surveillance colonoscopy in young patients with colorectal neoplasia. Gastrointest Endosc 2018;87:666–73.
Hemmasi G, Sohrabi M, Zamani F, et al. Prevalence of colorectal adenoma in an average-risk population aged 40-50 versus 50-60 years. Eur J Cancer Prev 2015;24:386–90.
Anderson JC, Calderwood AH, Christensen BC, et al. Smoking and other risk factors in individuals with synchronous conventional high-risk adenomas and clinically significant serrated polyps. Am J Gastroenterol 2018;113:1828–35.
Anderson JC, Latreille M, Messina C, et al. Smokers as a high-risk group: Data from a screening population. J Clin Gastroenterol 2009;43:747–52.
Anderson JC, Messina CR, Dakhllalah F, et al. Body mass index: A marker for significant colorectal neoplasia in a screening population. J Clin Gastroenterol 2007;41:285–90.
Anderson JC, Moezardalan K, Messina CR, et al. Smoking and the association of advanced colorectal neoplasia in an asymptomatic average risk population: Analysis of exposure and anatomical location in men and women. Dig Dis Sci 2011;56:3616–23.
Anderson JC, Rangasamy P, Rustagi T, et al. Risk factors for sessile serrated adenomas. J Clin Gastroenterol 2011;45:694–9.
Rex DK, Johnson DA, Anderson JC, et al. American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected]. Am J Gastroenterol 2009;104:739–50.